Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Braz. j. med. biol. res ; 54(9): e11097, 2021. tab, graf
Article in English | LILACS | ID: biblio-1278588

ABSTRACT

Pediatric epilepsy comprises chronic neurological disorders characterized by recurrent seizures. Sodium valproate is one of the common antiseizure medications used for treatment. Glucuronide conjugation is the major metabolic pathway of sodium valproate, carried out by the enzyme uridine 5′-diphosphate (UDP) glucuronosyl transferase (UGT) whose gene polymorphisms may alter the clinical outcome. The objective of this study was to assess the association between UGT1A6 genetic polymorphism and clinical outcome in terms of efficacy and tolerability in pediatric epileptic patients on sodium valproate monotherapy. Pediatric epileptic patients (n=65) aged 2-18 years receiving sodium valproate monotherapy for the past one month were included. Genetic polymorphism patterns of UGT1A6 (T19G, A541G, A552C) were evaluated by PCR-RFLP. Clinical outcome was seizure control during the 6 months observation period. Tolerability was measured by estimating the hepatic, renal, and other lab parameters. Out of 65 patients, TT (40%), TG (57%), and GG (3%) patterns were observed in UGT1A6 (T19G) gene, AA (51%), AG (40%), and GG (9%) in (A541G) gene, and AA (43%), AC (43%), and CC (14%) in (A552C) gene. No statistical difference in clinical outcome was found for different UGT1A6 genetic polymorphism patterns. We concluded that different patterns of UGT1A6 genetic polymorphism were not associated with the clinical outcome of sodium valproate in terms of efficacy and tolerability. Sodium valproate was well-tolerated among pediatric patients with epilepsy and can be used as an effective antiseizure medication.


Subject(s)
Humans , Child , Valproic Acid/therapeutic use , Epilepsy/genetics , Epilepsy/drug therapy , Seizures/genetics , Seizures/drug therapy , Polymorphism, Single Nucleotide , Anticonvulsants/therapeutic use
2.
Indian J Cancer ; 2006 Oct-Dec; 43(4): 151-5
Article in English | IMSEAR | ID: sea-50563

ABSTRACT

Oropharynx is an important site of cancer in India. Global comparison indicates higher incidences in India. Radiotherapy remains an important treatment modality. Efforts to improve loco-regional treatment and prolong survival are areas of focus. Radiosensitizers in hypoxic tumors have shown promise. AIM: To study the safety and radiosensitizing efficacy of sanazole in oropharyngeal squamous cell carcinoma (stage T2-4, N0-3, M0) as phase-II double blind controlled trial in patients treated with conventional radiotherapy. SETTINGS AND DESIGN: Single institutional, randomized, double-blind, placebo-controlled trial. MATERIALS AND METHODS: Group 1 (control; n = 23) received normal saline infusion, group 2 (test; n = 23) received sanazole biweekly 1.25 g intravenous infusion 15 minutes before radiotherapy. Surrogate end points of efficacy were tumor and nodal size; safety parameters were mucositis, salivary and skin reactions, dysphagia, vomiting, dysgeusia and neurological deficit. Investigators blinded to the trial evaluated patients, weekly during treatment for six weeks and thereafter monthly for three months. STATISTICAL METHODS: Non-parametric, Friedman's, Chi square, Mann-Whitney U tests. RESULTS: In the test, 15 (65%) patients had complete response, five (22%) partial/no response, two (9%) died, one (4%) lost to follow up. In the control, five (22%) patients had complete response, 16 (70%) partial/no response, one (4%) died, one (4%) lost to follow up. Short-term loco-regional response was better in the test (DF = 3, 95% Confidence Interval 0.418, 0.452, P = 0.0048). In the test group significant vomiting and one case of grade 3 neurological deficit was observed. CONCLUSION: The study validates the usefulness of sanazole for initial loco-regional control in oropharyngeal cancers.


Subject(s)
Adult , Aged , Combined Modality Therapy , Double-Blind Method , Female , Humans , Male , Middle Aged , Oropharyngeal Neoplasms/drug therapy , Radiation-Sensitizing Agents/therapeutic use , Treatment Outcome , Triazoles/therapeutic use
3.
Southeast Asian J Trop Med Public Health ; 1996 Dec; 27(4): 834-40
Article in English | IMSEAR | ID: sea-31745

ABSTRACT

A feasibility study to use remote sensing techniques for estimation of mosquito production in Sanjay lake in east Delhi was carried out. Besides the Sanjay lake, larval production for 12 surrounding remote sensing identifiable ponds was also estimated. Inspite of some limitations the technique is very useful for rapid mapping of major breeding sites, recording temporal changes and estimation of larval production in a cost effective manner in terms of survey cost and time.


Subject(s)
Animals , Culex , Geography , India , Larva , Mosquito Control
SELECTION OF CITATIONS
SEARCH DETAIL